These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17141623)

  • 1. Fat uses a TOLL-road to connect inflammation and diabetes.
    Kim JK
    Cell Metab; 2006 Dec; 4(6):417-9. PubMed ID: 17141623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Physiological and pathological role of adipose tissue innate immune system receptors].
    Shvarts V
    Patol Fiziol Eksp Ter; 2010; (3):45-51. PubMed ID: 20853621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innate immune pathway links obesity to insulin resistance.
    Shah PK
    Circ Res; 2007 Jun; 100(11):1531-3. PubMed ID: 17556663
    [No Abstract]   [Full Text] [Related]  

  • 4. Toll-like receptors, inflammation, metabolism and obesity.
    Fresno M; Alvarez R; Cuesta N
    Arch Physiol Biochem; 2011 Jul; 117(3):151-64. PubMed ID: 21599616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of inflammatory cytokines in diabetes and its complications.
    King GL
    J Periodontol; 2008 Aug; 79(8 Suppl):1527-34. PubMed ID: 18673007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity, inflammation, and insulin resistance--a mini-review.
    Zeyda M; Stulnig TM
    Gerontology; 2009; 55(4):379-86. PubMed ID: 19365105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity, inflammation, and insulin resistance.
    Shoelson SE; Herrero L; Naaz A
    Gastroenterology; 2007 May; 132(6):2169-80. PubMed ID: 17498510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The c-Jun N-terminal kinase mediates the induction of oxidative stress and insulin resistance by palmitate and toll-like receptor 2 and 4 ligands in 3T3-L1 adipocytes.
    Davis JE; Gabler NK; Walker-Daniels J; Spurlock ME
    Horm Metab Res; 2009 Jul; 41(7):523-30. PubMed ID: 19277946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity, inflammation, and vascular disease: the role of the adipose tissue as an endocrine organ.
    Calabro P; Yeh ET
    Subcell Biochem; 2007; 42():63-91. PubMed ID: 17612046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity as a link between obesity and insulin resistance.
    Kalupahana NS; Moustaid-Moussa N; Claycombe KJ
    Mol Aspects Med; 2012 Feb; 33(1):26-34. PubMed ID: 22040698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation.
    Suganami T; Mieda T; Itoh M; Shimoda Y; Kamei Y; Ogawa Y
    Biochem Biophys Res Commun; 2007 Mar; 354(1):45-9. PubMed ID: 17210129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Obesity, inflammation and diabetes].
    Miranda-Garduño LM; Reza-Albarrán A
    Gac Med Mex; 2008; 144(1):39-46. PubMed ID: 18619057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-107: a toll-like receptor-regulated miRNA dysregulated in obesity and type II diabetes.
    Foley NH; O'Neill LA
    J Leukoc Biol; 2012 Sep; 92(3):521-7. PubMed ID: 22645244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comment on: Reyna et al. (2008) Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects. Diabetes 57:2595-2602.
    Shapiro H; Singer P; Attal-Singer J
    Diabetes; 2009 Apr; 58(4):e5; author reply e6-7. PubMed ID: 19336685
    [No Abstract]   [Full Text] [Related]  

  • 15. Toll-like receptors: linking inflammation to metabolism.
    Könner AC; Brüning JC
    Trends Endocrinol Metab; 2011 Jan; 22(1):16-23. PubMed ID: 20888253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating transcription factor 3 constitutes a negative feedback mechanism that attenuates saturated Fatty acid/toll-like receptor 4 signaling and macrophage activation in obese adipose tissue.
    Suganami T; Yuan X; Shimoda Y; Uchio-Yamada K; Nakagawa N; Shirakawa I; Usami T; Tsukahara T; Nakayama K; Miyamoto Y; Yasuda K; Matsuda J; Kamei Y; Kitajima S; Ogawa Y
    Circ Res; 2009 Jul; 105(1):25-32. PubMed ID: 19478204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary lipids in early development: relevance to obesity, immune and inflammatory disorders.
    Innis SM
    Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):359-64. PubMed ID: 17940463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid peroxidation is not a prerequisite for the development of obesity and diabetes in high-fat-fed mice.
    Sohet FM; Neyrinck AM; Dewulf EM; Bindels LB; Portois L; Malaisse WJ; Carpentier YA; Cani PD; Delzenne NM
    Br J Nutr; 2009 Aug; 102(3):462-9. PubMed ID: 19161640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TANK-binding kinase 1 mediates phosphorylation of insulin receptor at serine residue 994: a potential link between inflammation and insulin resistance.
    Muñoz MC; Giani JF; Mayer MA; Toblli JE; Turyn D; Dominici FP
    J Endocrinol; 2009 May; 201(2):185-97. PubMed ID: 19251743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance.
    Kintscher U; Hartge M; Hess K; Foryst-Ludwig A; Clemenz M; Wabitsch M; Fischer-Posovszky P; Barth TF; Dragun D; Skurk T; Hauner H; Blüher M; Unger T; Wolf AM; Knippschild U; Hombach V; Marx N
    Arterioscler Thromb Vasc Biol; 2008 Jul; 28(7):1304-10. PubMed ID: 18420999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.